|
Biotech Business
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Total result: 410 articles |
 Page 1 of 6 
|
PROFECTUS BIOSCIENCES/MVI TO CONDUCT PROOF-OF-CONCEPT STUDY.
October 01, 2009
STEMEDICA REQUESTS PRE-IND MEETING WITH FDA.
October 01, 2009
FDA ACCEPTS SALIX NDA FOR PRIORITY REVIEW.
October 01, 2009
ENDOCYTE GETS MILESTONE PAYMENT FROM BRISTOL-METERS SQUIBB.
October 01, 2009
HAWAII BIOTECH BEGINS PHASE 1 CLINICAL TRIAL FOR DENGUE VACCINE.
October 01, 2009
PROJECT ZERO DELAY ACCELERATES DRUG'S PATH TO CLINICALTRIAL.
September 01, 2009
ADVANCED LIFE SCIENCES GETS LETTER FROM FDA FOR RESTANZA.
September 01, 2009
FDA LIFTS PARTIAL CLINICAL HOLD OF ICA-105665.
September 01, 2009
FDA APPROVES AVASTIN FOR THE MOST COMMON KIDNEY CANCER.
September 01, 2009
YAUPON ENROLLS PHASE 2 OF CLEARAZIDE FOR T-CELL LYMPHOMA.(Clinical rep...
August 01, 2009
JANET DAVIDSON AWARDED GRUBER GENETICS PRIZE.
August 01, 2009
ECI BIOTECH DEVELOPS EXPRESSDETECT FOR PATHOGEN DETECTION.
August 01, 2009
CARDIOXYL INITIATES PHASE I/IIA STUDY IN HEART FAILURE.
August 01, 2009
ALEXION'S SOLIRIS PREVENTS REJECTION IN KIDNEY TRANSPLANTS.(Clinical r...
July 01, 2009
HPV STATUS PREDICTS SURVIVAL IN OROPHARYNGEAL CANCERS.(Clinical report...
July 01, 2009
SHORT-COURSE RADIOTHERAPY EFFECTIVE FOR BONE METASTASES.
July 01, 2009
OSTEOLOGIX GETS PATENT ALLOWANCE FOR OSTEOPOROSIS DRUG.
July 01, 2009
WAFERGEN/DUKE UNIV. TO USE SMARTCHIP FOR SNP VALIDATION.
June 01, 2009
ICAGEN COMPLETES ENROLLMENT IN PHASE II ALERGEN ASTHMA TRIAL.(Clinical...
June 01, 2009
CHELSEA GETS POSITIVE RESULTS FROM PHASE I CH-4051 TRIAL.
June 01, 2009
COVANCE ADDS ALZEIMER'S ASSAY TO PORTFOLIO.
June 01, 2009
SCYNEXIS REPORTS SCY-635 POSITIVE SINGLE AGENT RESULTS.(Financial repo...
June 01, 2009
SMART CHIP SYSTEM USED TO EVALUATE HOMSPERA IN WOUND HEALING STUDIES.
May 01, 2009
NEW TEST MAY PREDICT BREAST CANCER METASTASIS.
May 01, 2009
ARUNA REPORTS COMMERCIAL DEBUT OF MESENCHYMAL CELLS.
May 01, 2009
ATON PHARMA AQUIRES MARKETING RIGHTS TO MERCK'S TIMOPTIC LINE.
April 01, 2009
PDS BIOTECHNOLOGY LICENSES MERCK EPROVA'S DOTAP CHLORIDE.
April 01, 2009
COMBIMATRIX TO LAUNCH NON-INVASIVE CANCER SCREENING TEST.
April 01, 2009
CHEMIMAGE OFFERS BIOEQUIVLANCE TECHNOLOGY FOR DRUG MAKERS.
April 01, 2009
RESVERATROL IN DARK CHOCOLATE & COCOA LEADS TO ANTI-AGING.
March 01, 2009
ARUNA BIOMEDICAL OFFERS EBRYONIC STEM CELL DERIVED NEURAL CELLS.
March 01, 2009
RXI PHARMACEUTICALS/MASS. MEDICAL SCHOOL GET RESEARCH GRANT.
March 01, 2009
CHELSEA THERAPEUTICS INITIATES PHASE II OF DROXIDOPA IN FIBROMYALGIA.(...
March 01, 2009
U.S. FDA APPROVES ORAQUICK ADVANCER 12-MONTH SHELF LIFE DATING.
March 01, 2009
LILLY WITHDRAWS CYMBALTA APPLICATION AND TO RESUBMIT IN 2009.
January 01, 2009
ANGIOGENEX REVIEWS 2008 AND SETS GOALS FOR 2009.
January 01, 2009
SIGMA-ALDRICH/D-FINITIVE CELL TO DEVELOP REGENERATIVE TOOLS.
January 01, 2009
FDA APPROVES PLC SYSTEMS PIVOTAL TRIAL OF RENALGUARD IN U.S.
January 01, 2009
NON-BRAIN PENETRANT CB1 ANTAGONISTS CAN TREAT DIABETES/OBESITY.
December 01, 2008
TOVAXIN REDUCES DISABILITY FOR MULTIPLE SCELEROSIS.(Clinical report)
December 01, 2008
ORASURE SUBMITS ORAQUICK HCV TEST PMA TO FDA.
December 01, 2008
ROCKWELL MEDICAL ANNOUNCES UPDATED DSMB RESULTS.(Financial report)
December 01, 2008
REPORT ON 633 BIOTECH MEDICINES UNDER DEVELOPMENT RELEASED.(Clinical r...
November 01, 2008
ALEXION'S SOLIRIS GETS 2008 PRIX GALIEN USA AWARD.
November 01, 2008
EMERGENT BIOSOLUTIONS/BARDA/NIAID SIGNS FOR UP TO $29.7 MIL.
November 01, 2008
CHEMBRIDGE/ASTRAZENECA FORM NEW DEVELOPMENT ALLIANCE.(Company overview...
November 01, 2008
NIH FUNDS DISCOVERY OF NEW INFLUENZA INHIBITORS.
October 01, 2008
DISCOVERY AEROSOLIZED KL-4 SURFACTANT SELECTED FOR PHASE 2A.(Clinical ...
October 01, 2008
CHELSEA PATIENT DOSING IN DROXIDOPA PHASE III.
October 01, 2008
NOVAVAX GETS GOOD RESULTS FROM PHASE I/IIA VACCINE STUDY.(Report)
October 01, 2008
ANTIDEPRESSANTS/COCAINE INTERACT WITH BRAIN CELL TARGETS.
September 01, 2008
PHARMACOPEIA EARNS MILESTONE PAYMENT FROM WYETH.
September 01, 2008
DISCOVERY LABS KL-4 DATA PUBLISHED IN PEDIATRIC RESEARCH.
September 01, 2008
LEXICON SUCCESSFULLY COMPLETES PAHSE I STUDY OF LX1031.
September 01, 2008
BAYER EXPANDS HEMOPHILIA PORTFOLIO FEATURING MAXY-VII.(Company overvie...
August 01, 2008
HANA BIOSCIENCES GETS U.S.ORPHAN DRUG DESIGNATION FOR MARQIBO.
August 01, 2008
SENESCO CHOOSES VGXI TO PRODUCE FACTOR 5A PLASMID.
August 01, 2008
REGENERX COMPLETES ENROLLMENT OF PHASE IA FOR HEART DRUG.
August 01, 2008
APP PHARMACEUTICALS GETS APPROVALS FOR ADDITIONAL DOSAGES.
August 01, 2008
MOLECULAR INSIGHT INITIATES PHASE 2A AZEDRA CLINICAL TRIAL.
June 01, 2008
FDA PROVIDES CLARITY TO ISIS ON MIPOMERSEN REQUIREMENTS.
June 01, 2008
DUSKA THERAPEUTICS PLANS NDA 505(B)(2) FILING FOR ATPACE.
June 01, 2008
METABASIS GETS GOOD RESULTS FROM MB07803 PHASE 2A TRIAL.
June 01, 2008
IMMUNEREGEN/DELSITE COLLABORATE ON NEW FLU TREATMENT.
May 01, 2008
WEILL CORNELL INDENTIFIES NEW FORM OF INHERITED CANCER RISK.
May 01, 2008
THE GI COMPANY TO PRESENT PHASE II ORAL MUCOSITIS DATA AT ASCO.
May 01, 2008
OXIGENE BEGINS PHASE II NSCLC TRIAL OF ZYBRESTAT WITH CHEMOTHERAPY.
May 01, 2008
WEILL CORNELL IDENTIFIES DRUG TARGETS FOR BREAST CANCER.
April 01, 2008
NEW ANTIBIOTIC HOLDS PROMISE FOR TREATMENT OF HELICOBACTOR.
April 01, 2008
ORTHOLOGIC DOSES FOR AZXIOO PHASE 1 DERMAL SCARRING.
April 01, 2008
ICA-1 COMPOUND HOLDS PROMISE AS CANCER TREATMENT.
April 01, 2008
MILLENNIUM/HARVARD MEDICAL SCHOOL SIGN CANCER RESEARCH PACT.
March 01, 2008
GENAERA FILES IND FOR TRODUSQUEMINE (MSI-1436).
March 01, 2008
CHDI FOUNDATION EVALUATES SIX SAMARITAN ALZHEIMER'S DRUGS.
March 01, 2008
CHELSEA THERAPEUTICS INITIATES PHASE II TRIAL OF CH-1504.(Medical cond...
March 01, 2008
|
1